TERENCE WILLIAMS: Open Payments
NPI 1942246913 · SURPRISE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$785 in 36 payments from 10 companies in 2025. Trend: 2023 $66 · 2024 $188 · 2025 $785
Food & beverage: $785
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $301 |
| AstraZeneca Pharmaceuticals LP | 5 | $167 |
| Novo Nordisk Inc | 5 | $101 |
| PFIZER INC. | 3 | $64 |
| GlaxoSmithKline, LLC. | 3 | $47 |
| Inspire Medical Systems, Inc. | 1 | $32 |
| Lilly USA, LLC | 2 | $28 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| Aimmune Therapeutics, Inc. | 1 | $14 |
Products named: VRAYLAR, FARXIGA, PREVNAR 20, Ozempic, QULIPTA, AIRSUPRA, INSPIRE, TRELEGY ELLIPTA.
Industry payments across AZ — which companies pay providers there.
